Product: GeneStrat
-
Costs and Outcomes Comparison of Tissue and Blood Based Biopsies for the Purpose of Biomarker Testing for Advanced Non-Small Cell Lung Cancer
-
Blood-based Profiling of NSCLC with CLIA certified cell-free DNA Tests for EGFR, KRAS and BRAF Point Mutations and Utility in Clinical Practice
-
Profiling Blood from NSCLC Patients for Clinically Actionable Gene Variants using GeneStrat
-
Development of a Rapid Blood-based Test for EGFR Sensitizing and Resistance Mutations in NSCLC
-
Rapid Blood-based Tests for ALK, RET and ROS1 mRNA Fusions and Somatic Variants in NSCLC